Dr Bill Nelson talks with Dr Rick Jones about the genesis of the bone marrow transplant program at Johns Hopkins, the breakthroughs over the last five decades that have led to increasingly better outcomes for patients, and the founder of the BMT Program, Dr George Santos.

Dr Bill Nelson and Dr Ross Donehower discuss the origins of the drug development program at our cancer center and the first director, Dr O. Michael Colvin.

In the next podcast looking back at the first 50 years of the cancer center at Johns Hopkins, Dr Bill Nelson speaks with Dr Steven Piantadosi about the origin of quantitative sciences in cancer research.

Dr Bill Nelson speaks with Dr Srinivasan Yegnasubramanian and Dr Sean Taverna about their research into cell function and how that knowledge can be used to detect and prevent disease.

Dr Bill Nelson and Dr Ted DeWeese, the interim Dean of Faculty and CEO of Johns Hopkins Medicine, review the history of radiation oncology at Johns Hopkins.

In this edition of our podcast series on the history of our cancer center, Dr Bill Nelson speaks to Ed Miller, the former Dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, about the second Director of the Johns Hopkins Kimmel Cancer Center, Dr Martin Abeloff.

Dr Bill Nelson speaks with Dr John Groopman from the Johns Hopkins Bloomberg School of Public Health about identifying the causes of cancer and developing strategies to prevent exposure and advance treatment methods.

Dr Ashwani Rajput talks with Dr Khaled El-Shami about the diagnosis, treatment, and care for patients with leukemias, lymphomas, and myelomas.

In the second edition of our podcast series looking back on the history of the Johns Hopkins Kimmel Cancer Center, Dr Bill Nelson speaks with Dr Donald Small, the Director of Pediatric Oncology, about the role Johns Hopkins played in the creation of the discipline of pediatric oncology.

Dr Akila Viswanathan and Dr Jean Wright discuss the most recent recommendations for treating breast cancer with radiation as part of our series for Seminars in Radiation Oncology.